Medicxi
eureKARE to use $60m financing to bolster next-generation European biotech companies
New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology
Verily and Janssen to collaborate on home-based COVID-19 immune response study
Study will collect information about how COVID-19 affects the immune system
European biotech: a new generation of leaders emerges
Three companies that are on the rise in biotech
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK
Novartis and J&J back latest €400m Medicxi biopharma fund
Growing appetite from European investors to back early-stage biotechs
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region
Gilead strikes $5.1bn deal to bolster ties with Galapagos
Big boost for Belgian biotech, without a buy-out
BioNTech raises €290m for mRNA cancer vaccine platform
Funds will help lead melanoma candidate progress
Citryll snares €15m backing for its autoimmune disease NETs
New approach to tackling diseases such as lupus, RA
J&J takes option on Genmab follow-up to Darzalex
Blockbuster partners look to next chapter - while takeover talk persists
Verily unveils next-gen trials alliance with Novartis, Pfizer
New data methods and tech will be used to streamline trials
Syncona launches another cell therapy company, Treg specialist Quell
Focuses on novel immune system approach